Acro Biomedical Co., Ltd. (ACBM) stock
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.56MP/E –Yield –
Acro Biomedical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Acro Biomedical's price to sales ratio was 17.5× on Jan 31, 2024, against 261.2× a year earlier. Over the last 5 years it ranged from 17.5× to 425.3×, with a median of 158.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 17.5× | +0.0 |
| 2023 | Dec 29, 2023 | 17.5× | −283.9 |
| 2022 | Dec 30, 2022 | 301.4× | +95.2 |
| 2021 | Dec 31, 2021 | 206.2× | +103.9 |
| 2020 | Dec 31, 2020 | 102.3× | −26.1 |
| 2019 | Dec 31, 2019 | 128.4× | +105.4 |
| 2018 | Dec 31, 2018 | 22.9× | – |
See a number that looks wrong?